MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study

K. Baik, M. Park, M. Kang, YJ. Park, SJ. Chung, K. Oh, SH. Kang, S. Koh (Seoul, Republic of Korea)

Meeting: 2025 International Congress

Keywords: Parkinsonism

Category: Parkinson’s Disease: Pharmacology and Medical Management

Objective: To investigate whether chronic kidney disease (CKD) and proteinuria are associated with mortality rates in patients with Parkinson’s disease (PD), using data from a large nationwide cohort

Background: Various comorbidities contribute to mortality in patients with PD. Although growing evidence demonstrates that CKD increases the risk of developing PD, the effect of CKD on all-cause mortality remains unclear.

Method: We enrolled 59,293 patients aged ≥40 years with de novo PD between 2009 and 2015, using de-identified data from the National Health Insurance Service. Cox proportional hazards regression analysis using the presence of CKD or proteinuria as a predictor was performed to investigate the association between CKD, proteinuria, and mortality. For sensitivity analysis, the degree of eGFR or proteinuria were used as predictors in place of CKD/proteinuria.

Results: PD patients with CKD (hazard ratio [HR]=1.240, 95% confidence interval [CI] 1.190– 1.283) and proteinuria (HR=1.543, 95% CI 1.457 – 1.634) had a higher risk of mortality, even after controlling for confounding factors. The degree of kidney dysfunction (p < 0.001) and proteinuria (p < 0.001) were associated with an increased HR for mortality. Furthermore, female patients with CKD were more vulnerable to mortality than male patients (p for sex × CKD < 0.001); however, there was no sex-specific vulnerability of proteinuria to mortality (p for sex × proteinuria = 0.603).

Conclusion: CKD and proteinuria were associated with a higher all-cause mortality in patients with PD in a dose-dependent manner. Furthermore, these results highlight that strategies for controlling kidney function are necessary to reduce mortality in patients with PD.

To cite this abstract in AMA style:

K. Baik, M. Park, M. Kang, YJ. Park, SJ. Chung, K. Oh, SH. Kang, S. Koh. Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/chronic-kidney-disease-proteinuria-and-mortality-risk-in-patients-with-parkinsons-disease-a-longitudinal-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/chronic-kidney-disease-proteinuria-and-mortality-risk-in-patients-with-parkinsons-disease-a-longitudinal-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley